0
Views
0
CrossRef citations to date
0
Altmetric
Review

Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update

&
Received 08 Mar 2024, Accepted 30 Jul 2024, Published online: 08 Aug 2024

Figures & data

Figure 1. Overview of simple genetic models (zebrafish, C. elegans and Drosophila) and rodent models that recapitulate ALS pathology. Abbreviations: LOF, loss of function; GOF, gain of function.

Figure 1. Overview of simple genetic models (zebrafish, C. elegans and Drosophila) and rodent models that recapitulate ALS pathology. Abbreviations: LOF, loss of function; GOF, gain of function.

Figure 2. Translational value of ALS animal models for therapy. Summary of small compounds and other therapeutic strategies that have been identified in various animal models of ALS and are currently in clinical trials, with the corresponding phase of development.

Figure 2. Translational value of ALS animal models for therapy. Summary of small compounds and other therapeutic strategies that have been identified in various animal models of ALS and are currently in clinical trials, with the corresponding phase of development.

Figure 3. Advantages and limitations of simple models (zebrafish, C. elegans and Drosophila) and rodent models for the translational research of new therapeutics for ALS.

Figure 3. Advantages and limitations of simple models (zebrafish, C. elegans and Drosophila) and rodent models for the translational research of new therapeutics for ALS.